• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期头颈部鳞状细胞癌同步给予两种标准化化疗和放疗方案:一项可行性研究。

Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.

作者信息

Benasso M, Corvò R, Numico G, Cavallari M, Blengio F, Sanguineti G, Rosso M, Merlano M

机构信息

Department of Medical Oncology I, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

出版信息

Anticancer Res. 1995 Nov-Dec;15(6B):2651-4.

PMID:8669841
Abstract

BACKGROUND

In advanced squamous cell carcinoma of the head and neck, the superiority of a chemo-radiotherapy combination over radiotherapy alone has been strongly suggested. However, the best modality to combine the two treatments has still to be determinated. A pilot study was designed, testing a combination of two standard chemo- and radiotherapy regimens concomitantly administered.

MATERIALS AND METHODS

26 patients, with unresectable squamous cell carcinoma of the head and neck, were treated with three cycles of chemotherapy (cisplatin 20 mg/m2/day and fluorouracil 200 mg/m2/day as an intravenous bolus, for 5 consecutive days, every 21) simultaneously delivered with radiation (66-70 Gy/33-35 fractions/7 weeks). In order to reduce the mucoseal toxicity. observed in the first 15 patients, 1 week of pause was inserted after the third week of treatment in the subsequent 11 patients.

RESULTS

Grade III-IV mucositis was detected in 40% of patients treated without pause after the third week of treatment and in 9% of those treated with. Complete responses were obtained in 13/26 patients (50%) and partial responses in 8/26 (31%). 1 stable disease, 3 early deaths (1 because of toxicity) and 1 lost before being evaluated were considered as treatment failures (19%).

CONCLUSIONS

This concomitant chemo-radiotherapy approach showed a good antitumour activity but mucoseal toxicity is too high if no pause is planned during the treatment.

摘要

背景

在晚期头颈部鳞状细胞癌中,强烈提示化疗与放疗联合应用优于单纯放疗。然而,两种治疗联合的最佳方式仍有待确定。设计了一项初步研究,测试两种标准化疗和放疗方案同时给药的联合方式。

材料与方法

26例不可切除的头颈部鳞状细胞癌患者接受三个周期的化疗(顺铂20mg/m²/天和氟尿嘧啶200mg/m²/天静脉推注,连续5天,每21天重复),同时进行放疗(66 - 70Gy/33 - 35次分割/7周)。为了降低在前15例患者中观察到的黏膜毒性,在随后的11例患者治疗的第三周后插入1周的休息期。

结果

在治疗第三周后未休息的患者中,40%检测到III - IV级黏膜炎,而休息的患者中为9%。26例患者中有13例(50%)获得完全缓解,8例(31%)获得部分缓解。1例病情稳定,3例早期死亡(1例因毒性),1例在评估前失访,这些被视为治疗失败(19%)。

结论

这种同步放化疗方法显示出良好的抗肿瘤活性,但如果在治疗期间不安排休息,黏膜毒性过高。

相似文献

1
Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.晚期头颈部鳞状细胞癌同步给予两种标准化化疗和放疗方案:一项可行性研究。
Anticancer Res. 1995 Nov-Dec;15(6B):2651-4.
2
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.顺铂、氟尿嘧啶和亚叶酸钙诱导化疗后联合顺铂同步放化疗用于晚期头颈癌患者的器官保留及治愈:长期随访
J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108.
3
Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).局部晚期头颈部鳞状细胞癌(SCCHN)患者中,超分割放疗与传统分割放疗联合多西他赛、顺铂和5-氟尿嘧啶(TPF)同步化疗的比较。
Cancer Chemother Pharmacol. 2007 Aug;60(3):399-406. doi: 10.1007/s00280-006-0370-y. Epub 2006 Nov 10.
4
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.一项III期研究,比较顺铂联合氟尿嘧啶与紫杉醇、顺铂和氟尿嘧啶诱导化疗,随后进行同步放化疗用于局部晚期头颈癌的疗效。
J Clin Oncol. 2005 Dec 1;23(34):8636-45. doi: 10.1200/JCO.2004.00.1990. Epub 2005 Nov 7.
5
Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.顺铂、氟尿嘧啶和左亚叶酸钙诱导化疗用于局部晚期头颈癌:MD安德森癌症中心的经验
Cancer J Sci Am. 1997 Mar-Apr;3(2):92-9.
6
Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: a pragmatic approach for locally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2006 May;42(5):517-25. doi: 10.1016/j.oraloncology.2005.10.004. Epub 2006 Feb 9.
7
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.药代动力学调节化疗联合顺铂作为可切除局部晚期头颈癌诱导化疗的疗效:II期研究
Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15.
8
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.采用化疗与放疗交替的方法治疗晚期头颈部鳞状细胞癌。
N Engl J Med. 1992 Oct 15;327(16):1115-21. doi: 10.1056/NEJM199210153271602.
9
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.头颈部鳞状细胞癌诱导和辅助化疗的II期研究。伊利诺伊癌症中心的长期分析。
Cancer. 1997 Feb 1;79(3):588-94.
10
Concomitant chemoradiotherapy for advanced head and neck cancer.晚期头颈癌的同步放化疗
Jpn J Clin Oncol. 1994 Apr;24(2):94-100.

引用本文的文献

1
Utility of the Midface Degloving Approach for Extended Exposure in Maxillary Pathologies.中面部去套状剥离术在上颌病变扩大暴露中的应用价值。
J Maxillofac Oral Surg. 2020 Jun;19(2):217-224. doi: 10.1007/s12663-019-01287-w. Epub 2019 Sep 18.
2
Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings.基于动态对比增强磁共振成像结果的药代动力学分析预测和监测口腔鳞状细胞癌对放化疗的反应。
Eur Radiol. 2011 Aug;21(8):1699-708. doi: 10.1007/s00330-011-2102-x. Epub 2011 Mar 12.
3
[Simultaneous radiochemotherapy with carboplatin in patients with inoperable advanced stage III and IV head and neck tumors].
[不可切除的晚期III期和IV期头颈部肿瘤患者同步卡铂放化疗]
Strahlenther Onkol. 1999 May;175(5):213-7. doi: 10.1007/BF02742398.